The authors captured an effect of the PNPLA3 I148M polymorphism on eGFR in NAFLD as well as in non-NAFLD groups, but the association was abolished in the latter group when potential confounders were taken into account. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.